tirzepatide injection uses | GLP1 | Medical Weight Loss Compounded Tirzepatide Online | Transparent

If this patient increases the dose to 15 mg (purple curve), then (a) increasing the dosing interval to 10 days reduces cost by 30% and maintains identical weight loss and (b) increasing the dosing interval to 14 days reduces cost by 50% and maintains 87% weight loss Figure 3D concerns a patient on 15 mg q1wk and shows that they can cut their costs in half and retain 79% of their weight loss

References Murakami T, Inagaki N, Kondoh H

Wegovy Patient Information Leaflet

What are the birth defects of semaglutide

Once-weekly semaglutide in adults with overweight or obesity (STEP 5)

All GLP1 receptor agonists currently available in Australia are administered once per week